prpf6-protein

PRPF6 Protein — Pre-mRNA Processing Factor 6

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">PRPF6 Protein (Prp6)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Pre-mRNA Processing Factor 6</td></tr>
<tr><td><strong>Gene</strong></td><td>[PRPF6](/genes/prpf6)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O94906](https://www.uniprot.org/uniprotkb/O94906/entry)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>Predicted; homologous structures available</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>98.6 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus (spliceosome)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Spliceosome component family</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>Ubiquitous; highest in brain, heart, testis</td></tr>
<tr><td><strong>Function</strong></td><td>Spliceosome assembly and catalytic steps</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

PRPF6 Protein — Pre-mRNA Processing Factor 6

<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">PRPF6 Protein (Prp6)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>Pre-mRNA Processing Factor 6</td></tr>
<tr><td><strong>Gene</strong></td><td>[PRPF6](/genes/prpf6)</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[O94906](https://www.uniprot.org/uniprotkb/O94906/entry)</td></tr>
<tr><td><strong>PDB ID</strong></td><td>Predicted; homologous structures available</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>98.6 kDa</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus (spliceosome)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Spliceosome component family</td></tr>
<tr><td><strong>Tissue Expression</strong></td><td>Ubiquitous; highest in brain, heart, testis</td></tr>
<tr><td><strong>Function</strong></td><td>Spliceosome assembly and catalytic steps</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>

Overview

PRPF6 (Pre-mRNA Processing Factor 6) is a highly conserved essential protein that plays a critical role in pre-mRNA splicing within the nucleus of eukaryotic cells. As a component of the U5 small nuclear ribonucleoprotein (snRNP), PRPF6 is required for the assembly and proper function of the spliceosome — the large ribonucleoprotein complex responsible for removing introns from pre-mRNA. The protein functions as a scaffold that stabilizes the spliceosome during the splicing reaction and participates in the catalytic steps of intron removal.

PRPF6 is ubiquitously expressed across all tissues, with particularly high levels in the brain, heart, and testis. Its essential role in fundamental cellular processes means that complete loss of PRPF6 function is lethal in all eukaryotes studied to date. However, partial loss-of-function mutations and dysregulation have been increasingly linked to human disease, particularly neurodegenerative conditions including amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), and potentially Alzheimer's disease. This makes PRPF6 a protein of significant interest at the intersection of basic RNA biology and translational disease research.

This comprehensive page provides detailed coverage of PRPF6's molecular structure, its normal functions in RNA processing, its involvement in neurological disorders, and emerging therapeutic strategies targeting splicing factors.

Structure and Molecular Architecture

PRPF6 is a large protein of approximately 898 amino acids with a molecular weight of about 98.6 kDa. While high-resolution structural data for human PRPF6 is limited, bioinformatic analyses and studies of homologous proteins from yeast and other organisms have provided significant insight into its architecture and functional domains.

Domain Organization

N-terminal Region:

• Contains multiple helical domains
• Involved in protein-protein interactions
• May contribute to snRNP integration

• HEAT repeat motifs (huntingtin, elongation factor 3, PP2A, TOR)
• Form elongated helical structures
• Mediate interactions with other spliceosomal proteins

• Additional interaction surfaces
• Post-translational modification sites
• Nuclear localization signals

Structure-Function Relationships

PRPF6's architecture reflects its role in spliceosome assembly:

Scaffold Function:

• Multiple HEAT repeats provide flexible protein interaction platforms
• Allows simultaneous binding to multiple spliceosomal components
• Stabilizes the U5 snRNP within the larger spliceosome

• HEAT repeat proteins can undergo significant conformational changes
• Required for the dynamic rearrangements during spliceosome assembly
• Enables interaction with different spliceosomal complexes

Post-translational Modifications

Phosphorylation:

• Multiple phosphorylation sites identified
• Phosphorylation may regulate spliceosome dynamics
• Cell cycle-dependent phosphorylation observed

• Arginine methylation documented
• May affect protein-protein interactions

Normal Function in RNA Processing

PRPF6 is an essential component of the spliceosome and performs critical functions in the removal of introns from pre-mRNA. Understanding its normal function requires appreciation of the broader context of spliceosome biology.

The Spliceosome and Pre-mRNA Splicing

The spliceosome is a large, dynamic ribonucleoprotein complex that carries out pre-mRNA splicing — the process by which non-coding introns are removed and coding exons are ligated together to produce mature messenger RNA.

Spliceosome Composition:

• Five small nuclear RNAs (snRNAs): U1, U2, U4, U5, U6
• Over 200 associated proteins
• Dynamic assembly through multiple stages

PRPF6 in the Spliceosome Cycle

PRPF6 is a component of the U5 snRNP, one of the building blocks of the spliceosome:

U5 snRNP Function:

• Recognizes the 3' splice site
• Contacts the 5' exon during the first transesterification
• Holds the 3' exon for ligation during the second step
• Critical for catalytic steps

• Stabilizes the U5 snRNP structure
• Facilitates interaction with other snRNPs
• Required for proper spliceosome assembly
• Participates in catalytic steps

Tissue-Specific Splicing

Beyond its essential splicing function, PRPF6 contributes to regulated splicing programs:

Alternative Splicing:

• PRPF6 levels influence alternative splicing patterns
• Changes in PRPF6 affect inclusion/exclusion of specific exons
• Important for generating protein diversity

• Brain expresses specific splicing isoforms
• Important for neuronal gene expression programs
• Regulates neural-specific exon inclusion

Role in the Nervous System

The high expression of PRPF6 in the brain, combined with its essential role in RNA processing, makes it particularly important for neuronal function and health. Dysregulation or mutation of PRPF6 has significant consequences for neuronal gene expression and survival.

Neuronal Gene Expression

Neurons rely heavily on regulated RNA processing due to their post-mitotic nature and complex morphology:

Alternative Splicing in Neurons:

• Neurons have the most complex alternative splicing programs
• PRPF6 contributes to neuron-specific splicing patterns
• Critical for generating diverse neuronal proteins

• Neuronal activity can modulate splicing factor function
• PRPF6 may respond to synaptic signaling
• Enables rapid changes in gene expression

Synaptic Function

Proper splicing is essential for synaptic function:

Synaptic Protein Expression:

• Many synaptic proteins require specific splicing
• PRPF6 dysfunction affects synaptic protein isoforms
• May alter receptor subunit composition

• Activity-dependent splicing contributes to plasticity
• PRPF6 levels may affect LTP and LTD
• Important for learning and memory

Glial Cells

PRPF6 also functions in glial cells:

Astrocyte Gene Expression:

• Astrocytes have complex splicing programs
• PRPF6 supports astrocyte-specific functions
• Relevant to neuroimmune responses

• Myelin gene expression requires proper splicing
• PRPF6 important for oligodendrocyte function
• May affect myelination and myelin maintenance

Role in Neurodegenerative Diseases

Mutations in splicing factors, including PRPF6, have been increasingly recognized as causes of or contributors to neurodegenerative diseases. The essential nature of splicing and the particular vulnerability of neurons to disrupted RNA processing make this connection biologically logical.

Amyotrophic Lateral Sclerosis (ALS)

ALS represents the disease most strongly linked to PRPF6 dysfunction:

PRPF6 Mutations in ALS:

• Rare missense mutations identified in ALS patients
• Mutations affect splicing function
• Contribute to disease pathogenesis

• Splicing disruption leads to aberrant gene expression
• Motor neurons particularly vulnerable
• Affects RNA metabolism pathways

• Multiple splicing factors mutated in ALS
• General spliceosome impairment observed
• Common pathway to motor neuron death

Spinal Muscular Atrophy (SMA)

SMA provides another example of splicing factor involvement in neurodegenerative disease:

SMN1 Deficiency:

• SMA caused by SMN1 deletion
• SMN essential for snRNP assembly
• Affects all splicing, including PRPF6-containing complexes

• Splicing modulation as therapeutic strategy
• ASO therapies targeting SMN2
• Broader applications to other splicing factors

Alzheimer's Disease

Emerging evidence links splicing dysfunction to Alzheimer's disease:

Altered Splicing Patterns:

• Global changes in alternative splicing in AD brain
• Specific splicing factor expression altered
• May contribute to disease pathology

• PRPF6 expression changes in AD models
• May affect APP and tau isoform expression
• Contributes to disease-relevant splicing changes

Other Neurological Disorders

Frontotemporal Dementia (FTD):

• TDP-43 pathology affects splicing regulation
• May intersect with PRPF6 function
• RNA metabolism disruption common feature

• Splicing changes observed in PD brain
• Potential for PRPF6 involvement
• Requires further investigation

Therapeutic Strategies

The involvement of splicing factors in disease has stimulated interest in therapeutic approaches targeting RNA splicing:

Antisense Oligonucleotides (ASOs)

ASO Approach:

• Single-stranded DNA oligonucleotides
• Designed to modulate splicing of specific genes
• Can restore proper splicing patterns

• Targeting mutant splicing factors
• Modulating expression of splicing regulators
• Currently approved for SMA (nusinersen)

Small Molecule Modulators

Spliceosome-Targeting Drugs:

• Drugs that modulate spliceosome function
• Some approved for cancer (e.g., spliceosome inhibitors)
• Potential for neurodegenerative disease

• Development of PRPF6-specific modulators
• Challenges in achieving selectivity
• Active research area

Gene Therapy

Viral Delivery:

• AAV vectors for gene delivery
• Express wild-type PRPF6
• Potential for certain mutations

• CRISPR-based approaches
• Correct disease-causing mutations
• Emerging therapeutic modality

Interaction Network

PRPF6 participates in a complex network of protein-protein interactions within the spliceosome:

U5 snRNP Components

| Partner Protein | Interaction | Function |
|-----------------|-------------|----------|
| PRPF8 | Direct interaction | Core U5 protein |
| BRR2 (SNRPA1) | Direct interaction | RNA helicase |
| SNRNP200 | Complex formation | Helixase activity |
| SNRNP40 | Direct interaction | U5 protein |

Spliceosome Assembly Factors

| Factor | Interaction | Stage |
|--------|-------------|-------|
| PRPF19 | Network interaction | Catalytic steps |
| CDC40 | Network interaction | Early stages |
| BUD31 | Network interaction | Assembly |

Nuclear Import Factors

| Factor | Function |
|--------|----------|
| Importin | Nuclear import |
| Transportin | Nuclear transport |

Animal Models and Research Findings

Model Systems

Yeast:

• Homologous protein Cwc24 (S. cerevisiae)
• Essential for viability
• Detailed mechanistic studies

• siRNA knockdown reveals essential function
• Loss leads to cell death
• Splicing defects documented

• Conditional knockouts in mice
• Drosophila models
• Zebrafish models

Key Findings

Essential Function:

• Complete knockout lethal
• Partial loss causes specific defects
• Different tissues show varying sensitivity

• Incomplete splicing activation
• Specific intron retention
• Alternative splicing alterations

Future Directions

Research Priorities

Unresolved Questions

• What determines neuronal specificity of splicing factor disease?
• Can spliceosome function be safely modulated therapeutically?
• What is the full extent of PRPF6's substrate specificity?
• Are there compensatory mechanisms that could be exploited?

See Also

• [PRPF6 Gene](/genes/prpf6)
• [Spliceosome](/mechanisms/spliceosome)
• [U5 snRNP](/mechanisms/u5-snrp)
• [Pre-mRNA Splicing](/mechanisms/pre-mrna-splicing)
• [Alternative Splicing](/mechanisms/alternative-splicing)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [RNA Processing](/mechanisms/rna-processing)
• [RNA Binding Proteins](/mechanisms/rna-binding-proteins)

External Links

• [UniProt: PRPF6 (O94906)](https://www.uniprot.org/uniprotkb/O94906/entry)
• [RCSB PDB: Homologous Structures](https://www.rcsb.org/)
• [NCBI Gene: PRPF6](https://www.ncbi.nlm.nih.gov/gene/24148)
• [Homo sapiens Spliceosome Pathway (KEGG)](https://www.genome.jp/kegg/pathway/map03040)

References